Design and Evaluation of Highly Selective Dopamine D4 Receptor Ligands as a Strategy for Treating Neuropsychiatric Disorders (Abstract ID: 236234)
The Journal of Pharmacology and Experimental Therapeutics · 2026-05 · 393 (5) · 104109
DOI: 10.1016/j.jpet.2026.104109 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Pharmacology and Experimental Therapeutics, 2026-05. Verfasst von Mohammad Alkhatib und 6 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Alkhatib, M., Li, T., Nguyen, N., Bourn, L., Rainwater, S. J., Boateng, C. A., & Keck, T. (2026). Design and Evaluation of Highly Selective Dopamine D4 Receptor Ligands as a Strategy for Treating Neuropsychiatric Disorders (Abstract ID: 236234). The Journal of Pharmacology and Experimental Therapeutics, 393(5), 104109. https://doi.org/10.1016/j.jpet.2026.104109
Vancouver
Alkhatib M, Li T, Nguyen N, Bourn L, Rainwater SJ, Boateng CA, et al. Design and Evaluation of Highly Selective Dopamine D4 Receptor Ligands as a Strategy for Treating Neuropsychiatric Disorders (Abstract ID: 236234). The Journal of Pharmacology and Experimental Therapeutics. 2026;393(5):104109. doi:10.1016/j.jpet.2026.104109
BibTeX
@article{Alkhatib2026,
author = {Alkhatib, Mohammad and Li, Tian and Nguyen, Norman and Bourn, Lindsay and Rainwater, Salem J. and Boateng, Comfort A. and Keck, Thomas},
title = {Design and Evaluation of Highly Selective Dopamine D4 Receptor Ligands as a Strategy for Treating Neuropsychiatric Disorders (Abstract ID: 236234)},
journal = {The Journal of Pharmacology and Experimental Therapeutics},
year = {2026},
volume = {393},
number = {5},
pages = {104109},
doi = {10.1016/j.jpet.2026.104109}
}
EUVIMED